Phreesia Inc. (PHR) Misses Q4 EPS by 8c, Revenues Beat; Offers FY22 Mid-Point Guidance Above Consensus

Phreesia Inc. (NYSE: PHR) reported Q4 EPS of ($0.18), $0.08 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $41.8 million versus the consensus estimate of $39.35 million.

Fiscal Fourth Quarter 2021 Highlights

• Revenue was $41.8 million in the quarter, up 27% year-over-year.
• Average number of provider clients was 1,808 in the quarter, up 13% year-over-year.
• Average revenue per provider client was $17,858, up 7% year-over-year.
• Adjusted EBITDA was negative $0.09 million in the quarter compared to $1.3 million in the same period in the prior year.
• Cash as of January 31, 2021 was $218.8 million, down $35.3 million from October 31, 2020.

"Our team’s strength and resilience throughout a challenging fiscal 2021 supported our clients and helped drive our financial results. We are proud to support the incredible ongoing efforts of healthcare providers across the country while furthering Phreesia's mission of creating a better, more engaging healthcare experience," said Phreesia CEO Chaim Indig.

GUIDANCE:

Phreesia Inc. sees FY2022 revenue of $178-186 million, versus the consensus of $180.48 million.

• For the full fiscal year 2022, ending January 31, 2022, the Company expects revenue to be between $178 million and $186 million, consistent with its previous growth guidance of 20 to 25 percent over fiscal year 2021.

For earnings history and earnings-related data on Phreesia Inc. (PHR) click here.

You May Also Be Interested In

• Celanese Corp. (CE) Tops Q1 EPS by 50c, Revenues Beat; Raises 2Q & FY21 EPS Guidance Above Consensus
• Intel (INTC) Tops Q1 EPS by 24c, Offers Guidance
• Clearfield, Inc. (CLFD) Tops Q2 EPS by 10c, Revenues Beat